Kitsap County home listings asked for more money in May - see the current median price here
Compared to May 2024, the median home list price increased 8.2% from $637,485.
The statistics in this article only pertain to houses listed for sale in Kitsap County, not houses that were sold. Information on your local housing market, along with other useful community data, is available at datacentral.kitsapsun.com.
Kitsap County's median home was 2,124 square feet, listed at $337 per square foot. The price per square foot of homes for sale is up 7.9% from May 2024.
Listings in Kitsap County moved steadily, at a median 30 days listed compared to the May national median of 51 days on the market. In the previous month, homes had a median of 35 days on the market. Around 492 homes were newly listed on the market in May, a 12.3% increase from 438 new listings in May 2024.
The median home prices issued by Realtor.com may exclude many, or even most, of a market's homes. The price and volume represent only single-family homes, condominiums or townhomes. They include existing homes, but exclude most new construction as well as pending and contingent sales.
In Washington, median home prices were $670,000, a slight increase from April. The median Washington home listed for sale had 1,951 square feet, with a price of $358 per square foot.
Throughout the United States, the median home price was $440,000, a slight increase from the month prior. The median American home for sale was listed at 1,840 square feet, with a price of $234 per square foot.
The median home list price used in this report represents the midway point of all the houses or units listed over the given period of time. Experts say the median offers a more accurate view of what's happening in a market than the average list price, which would mean taking the sum of all listing prices then dividing by the number of homes sold. The average can be skewed by one particularly low or high price.
The USA TODAY Network is publishing localized versions of this story on its news sites across the country, generated with data from Realtor.com. Please leave any feedback or corrections for this story here. This story was written by Ozge Terzioglu. Our News Automation and AI team would like to hear from you. Take this survey and share your thoughts with us.
This article originally appeared on Kitsap Sun: Kitsap County home listings asked for more money in May - see the current median price here
Solve the daily Crossword
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
7 minutes ago
- Forbes
Sell Merck Stock Ahead Of Its Upcoming Earnings?
CHONGQING, CHINA - JULY 27: In this photo illustration, a person holds a smartphone displaying the ... More logo of Merck & Co., Inc. (NYSE: MRK), a leading American multinational pharmaceutical company, with the company's iconic green and white emblem visible in the background, on July 27, 2025 in Chongqing, China. (Photo illustration by) Merck (NYSE:MRK) is set to reveal its earnings on Tuesday, July 29, 2025. Historically, MRK stock has exhibited a trend of negative one-day returns following earnings announcements. In the past five years, the stock saw a decline on the day following earnings in 60% of occurrences. The median one-day drop was -2.1%, with the largest single-day decrease reaching -9.8%. Although the actual results relative to consensus estimates will be significant, recognizing these historical patterns can give an edge to event-driven traders. There are two main strategies to utilize this information: Analysts anticipate earnings of $2.03 per share on revenue of $15.87 billion for the forthcoming quarter. This indicates a slight reduction compared to the earnings of $2.28 per share on sales of $16.11 billion from the same quarter last year. This expected decrease in sales is primarily due to ongoing difficulties faced by Gardasil in China, despite the continued growth in Keytruda sales. Additionally, see – Merck's Keytruda Dependency: A Growth Story With An Expiration Date. From a fundamental viewpoint, Merck currently has a market capitalization of approximately $212 billion. Over the past twelve months, the company generated $64 billion in revenue, and was operationally profitable with $20 billion in operating profits and a net income of $17 billion. That being said, if you are looking for upside with lower volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — having outperformed the S&P 500 and produced returns exceeding 91% since its inception. View earnings reaction history of all stocks Merck's Historical Odds Of Positive Post-Earnings Return Insights on one-day (1D) post-earnings returns: Additional data for the observed 5-Day (5D) and 21-Day (21D) returns post earnings are summarized along with the statistics in the table below. MRK 1D, 5D, and 21D Post Earnings Return Correlation Between 1D, 5D, and 21D Historical Returns A relatively low-risk strategy (though not beneficial if the correlation is weak) is to understand the relationship between short-term and medium-term returns after earnings, identify a pair with the highest correlation, and execute the suitable trade. For instance, if 1D and 5D exhibit the strongest correlation, a trader can position themselves 'long' for the next 5 days if the 1D post-earnings return is positive. Here is some correlation data based on 5-year and more recent 3-year history. Note that the correlation 1D_5D refers to the correlation between 1D post-earnings returns and subsequent 5D returns. MRK Correlation Between 1D, 5D and 21D Historical Returns Is There Any Correlation With Peer Earnings? Occasionally, the performance of peers can influence the post-earnings reaction of stocks. In fact, the pricing-in might start ahead of the earnings announcement. Below is some historical data comparing Merck's post-earnings performance with that of peers who reported earnings just prior to Merck. For a fair comparison, peer stock returns also represent post-earnings one-day (1D) returns. MRK Correlation With Peer Earnings Find out more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (a combination of all 3, the S&P 500, S&P mid-cap, and Russell 2000), delivering strong returns for investors. Alternatively, if you desire upside with a smoother experience than an individual stock like Merck, consider the High Quality portfolio, which has surpassed the S&P, achieving >91% returns since inception.
Axios
8 minutes ago
- Axios
Tariff revenue is spiking. But who exactly is paying?
Tariffs are making money for the U.S. government, but it remains hard to tell who is footing the bill. Why it matters: Knowing who is paying the tariffs will help investors gauge which companies will see profits squeezed — or protected — as trade tensions continue. By the numbers: The government generated an extra $20 billion for each of the last two months, which could total $240 billion in additional revenue this year, according to Peter Tchir, head of macro strategy at Academy Securities. Where it's from: Motor vehicles brought in $3.4 billion, or over 14% of the $24.2 billion in total tariff revenue for May, according to data reviewed by Jason Miller, interim chair of supply chain management at Michigan State University. Vehicle parts added $1.2 billion in tariff revenue, while lithium-ion electric vehicle batteries contributed nearly $480 million. Case in point: GM disclosed $1.1 billion in tariff costs for the second quarter, which aligns with government data, Miller noted. European automaker Volkswagen reported a $1.5 billion tariff hit and cut its outlook, citing fallout from President Trump's trade war. Zoom out: What matters isn't just the tariff rate, but who pays along the chain: a foreign exporter, a U.S. importer, a distributor, or ultimately, the American consumer. Within autos, "there just isn't the demand right now in order to justify essentially charging higher rates," Miller told Axios, which means that companies like GM and Ford may struggle to pass costs to consumers. Zoom in: There are potential winners and losers in this trade war. Industrials are exposed, said David Bianco, chief investment officer for the Americas at DWS, with $1 trillion in managed assets. The biggest retailers will "gain market share" because they can negotiate favorable terms with suppliers, while smaller firms will struggle, he told Axios. Health care, the worst-performing sector year-to-date, may continue lagging as inflation weighs on consumers. Nvidia and other high-margin technology companies with carveouts are less vulnerable, according to Miller. How it works: Who ultimately pays for the tariffs depends on supply and demand dynamics. There are two key factors. Consumer demand: Weak demand means less pricing power, and companies may have to absorb the cost or risk losing customers. Exporter supply: Retailers have more flexibility to shift supply chains, while manufacturers of complex goods are often locked in. Data show retailers more often eat tariff costs than exporters of machines, which require more intricate work and quality control, leaving exporters in a power position on pricing. Yes, but: Pricing isn't static. Many companies set prices annually, which means the full effect may not be clear until next year.
Axios
8 minutes ago
- Axios
Investors celebrate trade deals inking higher tariffs
President Trump announced a 15% tariff on the European Union on Sunday. Stocks edged higher on the news, as investors see the deal easing the risk of even steeper tariffs. Why it matters: While investors cheer the short-term clarity, they could be underestimating the long-term drag of higher tariffs on corporate earnings. Driving the news: The 15% tariff on E.U. goods comes alongside a 0% tariff rate on American exports to Europe. The deal also includes pledges from the E.U. to buy over $750 billion in U.S. energy, invest $600 billion more in the U.S. economy, and open markets to American manufacturers and defense firms. Meanwhile, Commerce Secretary Howard Lutnick said tariff deadlines more broadly are firm, which means they will go into effect August 1. Zoom in: The euro rallied against the dollar in response to the trade deal news, and risk assets such as bitcoin rallied as well. Safe-haven assets like gold and the dollar were under pressure. What they're saying: "The biggest piece in the trade deal puzzle still remains, and the Chinese are unlikely to be as willing to fold," Jamie Cox, a managing partner at Harris Financial Group, wrote in a note. China is now the biggest focus for investors, as Axios Markets reported. Public companies rely on China for access to lower priced goods and labor. Chinese consumers also prop up U.S. companies, with 7% of the S&P 500's annual revenue coming from China, according to Apollo chief economist Torsten Slok. Be smart: While tariff rates on China are the biggest country-specific tariff risk for investors, sector-specific levies are also of concern. Lutnick said sector tariffs would become clear over roughly the next two weeks. Any clarity on sector tariffs could move stocks in those baskets.
